HEADER G-PROTEIN 02-MAY-97 1AJE TITLE CDC42 FROM HUMAN, NMR, 20 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: CDC42HS; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: SEVEN NON-NATIVE AMINO ACIDS REMAIN AT THE N-TERMINUS COMPND 6 AFTER CLEAVAGE OF THE FUSION PROTEIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: BL21; SOURCE 6 ORGAN: PLACENTA; SOURCE 7 CELLULAR_LOCATION: MEMBRANES AND GOLGI; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: TG1, BL21 AND DL39; SOURCE 11 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 13 EXPRESSION_SYSTEM_VECTOR: PGEX; SOURCE 14 EXPRESSION_SYSTEM_PLASMID: PGEX-CDC42HS KEYWDS G-PROTEIN, CELLULAR SIGNALING, CYTOSKELETAL REARRANGEMENT EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR J.L.FELTHAM,V.DOTSCH,S.RAZA,D.MANOR,R.A.CERIONE,M.J.SUTCLIFFE, AUTHOR 2 G.WAGNER,R.E.OSWALD REVDAT 3 16-FEB-22 1AJE 1 REMARK REVDAT 2 24-FEB-09 1AJE 1 VERSN REVDAT 1 12-NOV-97 1AJE 0 JRNL AUTH J.L.FELTHAM,V.DOTSCH,S.RAZA,D.MANOR,R.A.CERIONE, JRNL AUTH 2 M.J.SUTCLIFFE,G.WAGNER,R.E.OSWALD JRNL TITL DEFINITION OF THE SWITCH SURFACE IN THE SOLUTION STRUCTURE JRNL TITL 2 OF CDC42HS. JRNL REF BIOCHEMISTRY V. 36 8755 1997 JRNL REFN ISSN 0006-2960 JRNL PMID 9220962 JRNL DOI 10.1021/BI970694X REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.843 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE. REMARK 4 REMARK 4 1AJE COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170889. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; TOCSY; HSQC; HNCO; HNCA; REMARK 210 HN(CO)CA; CBCA(CO)NH; HCACO; REMARK 210 TOCSY-HSQC; HCCH-TOCSY; NOESY- REMARK 210 HSQC; HMQC-NOESY-HMQC REMARK 210 SPECTROMETER FIELD STRENGTH : 400 MHZ; 500 MHZ; 600 MHZ; 700 REMARK 210 MHZ REMARK 210 SPECTROMETER MODEL : UNITY (500 MHZ); UNITY INOVA REMARK 210 (600 MHZ; UNITY PLUS (400; 750 REMARK 210 MHZ) REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR 3.843 REMARK 210 METHOD USED : DISTANCE GEOMETRY FOLLOWED BY REMARK 210 SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST OVERALL ENERGY AND LOWEST REMARK 210 CONSTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 DBREF 1AJE A 1 187 UNP P60953 CDC42_HUMAN 1 187 SEQRES 1 A 194 GLY SER LYS ILE ILE SER ALA MET GLN THR ILE LYS CYS SEQRES 2 A 194 VAL VAL VAL GLY ASP GLY ALA VAL GLY LYS THR CYS LEU SEQRES 3 A 194 LEU ILE SER TYR THR THR ASN LYS PHE PRO SER GLU TYR SEQRES 4 A 194 VAL PRO THR VAL PHE ASP ASN TYR ALA VAL THR VAL MET SEQRES 5 A 194 ILE GLY GLY GLU PRO TYR THR LEU GLY LEU PHE ASP THR SEQRES 6 A 194 ALA GLY GLN GLU ASP TYR ASP ARG LEU ARG PRO LEU SER SEQRES 7 A 194 TYR PRO GLN THR ASP VAL PHE LEU VAL CYS PHE SER VAL SEQRES 8 A 194 VAL SER PRO SER SER PHE GLU ASN VAL LYS GLU LYS TRP SEQRES 9 A 194 VAL PRO GLU ILE THR HIS HIS CYS PRO LYS THR PRO PHE SEQRES 10 A 194 LEU LEU VAL GLY THR GLN ILE ASP LEU ARG ASP ASP PRO SEQRES 11 A 194 SER THR ILE GLU LYS LEU ALA LYS ASN LYS GLN LYS PRO SEQRES 12 A 194 ILE THR PRO GLU THR ALA GLU LYS LEU ALA ARG ASP LEU SEQRES 13 A 194 LYS ALA VAL LYS TYR VAL GLU CYS SER ALA LEU THR GLN SEQRES 14 A 194 LYS GLY LEU LYS ASN VAL PHE ASP GLU ALA ILE LEU ALA SEQRES 15 A 194 ALA LEU GLU PRO PRO GLU PRO LYS LYS SER ARG ARG HELIX 1 A1 LYS A 16 THR A 25 1 10 HELIX 2 A3 PHE A 90 HIS A 103 1 14 HELIX 3 AI SER A 124 LYS A 128 1 5 HELIX 4 A4 THR A 141 ARG A 147 1 7 HELIX 5 A5 LEU A 165 LEU A 177 1 13 SHEET 1 B 6 LYS A 153 VAL A 155 0 SHEET 2 B 6 PRO A 109 GLY A 114 1 N LEU A 112 O LYS A 153 SHEET 3 B 6 VAL A 77 CYS A 81 1 N VAL A 80 O LEU A 111 SHEET 4 B 6 ILE A 4 VAL A 9 1 N VAL A 7 O VAL A 77 SHEET 5 B 6 GLU A 49 PHE A 56 1 N PHE A 56 O CYS A 6 SHEET 6 B 6 TYR A 40 MET A 45 -1 N VAL A 42 O LEU A 53 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1